Other Haematological Agents
Other Haematological Agents Companies (4)
Other Haematological Agents News
-
News Pfizer boosts rare disease pipeline with $5.4B acquisition of Global Blood Therapeutics
The $5.4 billion deal marks Pfizer's fourth acquisition in the last nine months
Other Haematological Agents Products (3)
-
Product Hemax 1.000/2.000/3.000/4.000/10.000/20.000/40.000 IU
Hemax is a synthetic form of human erythropoietin, used to treat anemia. Biosidus recombinant human erythropoietin, our flagship product, is obtained by mass cell culture of genetically modified mammalian cells. Our epoetin is available in a convenient thermostable formulation as freeze dried powder for in... -
Product Epoetin 2000 IU SEDICO Injection
http://www.sedico.net/English/products/webpages/Epoetin2000&4000/Epoetin2000&4000_e.htm -
Product HAEMODIALYSIS - TETRA DEXTROSE TYPE (D 01)
PART A
Each 1000 ml contains
Ingredients
gm
Mmol
Sodium Chloride
161.90
2770
Potassium Chloride q...
Upcoming Events
-
CPHI Middle East 2024
Riyadh Front Exhibition & Convention Center Riyadh, Saudi Arabia
10 Dec 2024 - 12 Dec 2024 -
Pharmapack Europe 2025
Paris Expo, Porte de Versailles - Hall 7.2 | Paris, France
22 Jan 2025 - 23 Jan 2025 -
CPHI Japan 2025
East Halls 4, 5 & 6, Tokyo Big Sight, Tokyo, Japan
09 Apr 2025 – 11 Apr 2025
Pharmaceutical Industry Webinars
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance